Drug Search Results
More Filters [+]

Niflumic acid

Alternative Names: niflumic acid
Latest Update: 2024-01-06
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Belgium | Chile | Dominican Republic | Egypt | France | Greece | Hungary | India | Ireland | Italy | Luxembourg | Morocco | Pakistan | Peru | Portugal | Spain | Taiwan | Tunisia

Approved Indications: None

Known Adverse Events: None

Company: University Hospital Of Clermont-Ferrand
Company Location:
Company CEO:
Additonal Commercial Interests: None

Clinical Description

Map of Global Clinical Trials for Niflumic acid

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Phase 4: Osteoarthritis, Knee|Osteoarthritis, Hip

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

RBHP 2022 DUALE

P4

Not yet recruiting

Osteoarthritis, Knee|Osteoarthritis, Hip

2025-03-01

Recent News Events